QOLDQuality of Life and Depression in Peritoneal Dialysis Patients and Hemodialysis Patients
Data Collection
Collected from today forward - ProspectiveUrogenital Diseases+12
+ Behavior
+ Behavioral Symptoms
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: August 1, 2010
Actual date on which the first participant was enrolled.In dialysis patients, low QOL and depression affects clinical outcomes such as morbidity and mortality. Therefore at the point of treating dialysis patients, It is important to provide not only physical health but also psychosocial health. QOL could be decided by physical health (i.e. sign and symptom, laboratory results, death) and psychological health (i.e. fatigue, pain, consciousness of health and satisfaction). And also generally it is well known that physical and psychological functions in dialysis patients are decreased. And especially depression is common disease in dialysis patients. It is also well known that about from 25 to 50 percent of dialysis patients have depression which could result in low QOL moreover hospitalization, complication, and mortality. But there is no QOL and depression study with hydration status. Therefore the investigators would like to explore it. The objective of the study is to evaluate quality of life (QOL) and depression in dialysis patients and assess the hydration effect on QOL and depression over time
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.1068 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Dialysis patients, age from 18 years to 75 years Incident continuous ambulatory peritoneal dialysis(CAPD) or automated peritoneal dialysis(APD) patients who don't have any experience of dialysis treatment before this study Prevalent peritoneal dialysis(PD) patients who are getting peritoneal dialysis treatment more than 6 months Prevalent hemodialysis (HD) patients who are getting haemodialysis treatment more than 6 months The subjects who are eligible for 1 year follow up Written informed consent before any trial related activities Eligible patients to complete questionnaire Exclusion Criteria: Prognosis for survival less than 3 months Kidney transplantation less than 15 months Ineligible patients for questionnaire Any malignancies and ascites Any condition which could interfere with the patient's ability to comply with the study protocol Ineligible to measure BCM pacemaker, defibrillator pregnancy or lactation period amputation artificial joint
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location